Titulo:

Prediction of cardiotoxicity in breast cancer patients exposed to anthracyclines during trastuzumab treatment.
.

Guardado en:

2256-2877

2256-2915

11

2024-12-05

22

34

http://purl.org/coar/access_right/c_abf2

info:eu-repo/semantics/openAccess

Revista colombiana de hematología y oncología - 2024

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

id metarevistapublica_acho_revistacolombianadehematologiayoncologia_27-article-703
record_format ojs
spelling Prediction of cardiotoxicity in breast cancer patients exposed to anthracyclines during trastuzumab treatment.
11
Medina Pabón , Miguel Ángel
Revista Colombiana de Hematología y Oncología
Bogotá: Asociación Colombiana de Hematología y Oncología, 2012-
Núm. 2 , Año 2024 : Julio - Diciembre
2
Artículo de revista
Gómez Wolff, Luis Rodolfo
Jaramillo Gómez , Nicolás Ignacio
Tatis Mendez, Jose Fidel
Llamas Jiménez , Alexis del Carmen
Lopera Arrázola , Nicolás
Journal article
Cao L, Hu WG, Kirova YM, et al. Potential impact of cardiac dose-volume on acute cardiac toxicity following concurrent trastuzumab and radiotherapy. Cancer Radiother. [internet] 2014; 18:119–124. Available from: https://doi.org/10.1016/j.canrad.2014.01.001 PMID: 24642505.
Abouegylah M, Braunstein LZ, Alm El-Din MA, et al. Evaluation of radiation-induced cardiac toxicity in breast cancer patients treated with trastuzumab-based chemotherapy. Breast Cancer Res Treat. [internet] 2019; 174:179–185. Available from: https://doi.org/10.1007/s10549-018-5053-y PMID: 30478787. PMCID: PMC8590794.
El-Sherbeny WS, Sabry NM, Sharbay RM. Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy. J Echocardiogr. [internet] 2019; 17(2):76-83. Available from: https://doi.org/10.1007/s12574-018-0394-4 Epub 2018 Aug 11. PMID: 30099714.
Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). European Heart Journal, [internet] 2022; 43(41): 4229–4361. Available from: https://doi.org/10.1093/eurheartj/ehac244
http://purl.org/coar/access_right/c_abf2
Oikonomou EK, Kokkinidis DG, Kampaktsis PN, Amir EA, Marwick TH, Gupta D, et al. Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis. JAMA Cardiol. [internet] 2019;4(10):1007-1018. Available from: https://doi.org/10.1001/jamacardio.2019.2952 PMID: 31433450; PMCID: PMC6705141.
Sengupta PP, Northfelt DW, Gentile F, Zamorano JL, Khandheria BK. Trastuzumab-induced cardiotoxicity: heart failure at the crossroads. MayoClin Proc. [internet] 2008; 83(2):197-203. Available from: https://doi.org/10.4065/83.2.197 PMID: 18241629.
lana JC, Galderisi M, Barac A, et al: Expert consensus formultimodality imaging evaluation of adult patients dur-ing and after cancer therapy: A report from the AmericanSociety of Echocardiographic and the European Associa-tion of Cardiovascular Imaging.J Am Soc Echocardiogr. [internet] 2014;27:911–939. Available from: https://doi.org/10.1016/j.echo.2014.07.012 PMID: 25172399
Lax J, Piñeiro D. Consenso de diagnóstico, prevención y tratamiento de la cardiotoxicidad por tratamiento médico del cáncer. Versión resumida. Rev Argent Cardiol. [internet] 2013; 81(6):530-6. Available from: http://dx.doi.org/10.7775/rac.es.v81.i6.3537
Fei HW, Ali MT, Tan TC, Cheng KH, Salama L, Hua L, Zeng X, Halpern EF, Taghian A, MacDonald SM, Scherrer-Crosbie M. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction. Echocardiographic. [internet] 2016; 33(4):519-26. Available from: https://doi.org/10.1111/echo.13168 Epub 2016 Mar 16. PMID: 26992012
Tarantini L, Cioffi G, Gori S, Tuccia F, Boccardi L, Bovelli D, Lestuzzi C, Maurea N, Oliva S, Russo G, Faggiano P; Italian Cardio-Oncologic Network. Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer. J Card Fail. [internet] 2012; 18(2):113-9. Available from: https://doi.org/10.1016/j.cardfail.2011.10.015. PMID: 22300778
Arciniegas Calle MC, Sandhu NP, Xia H, Cha SS, Pellikka PA, Ye Z, et al. Two-dimensional speckle tracking echocardiographic predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer. BMC Cancer. [internet] 2018;18(1):1037. Available from: https://doi.org/10.1186/s12885-018-4935-z PMID: 30359235; PMCID: PMC6203211.
Jawa Z, Perez RM, Garlie L, Singh M, Qamar R, Khandheria BK, Jahangir A, Shi Y. Risk factors of trastuzumab-induced cardiotoxicity in breast cancer: A meta-analysis. Medicine (Baltimore). [internet] 2016 Nov;95(44):e5195. Available from: https://doi.org/10.1097/MD.0000000000005195 PMID: 27858859; PMCID: PMC5591107.
Bergom C, Bradley JA, Ng AK, Samson P, Robinson C, Lopez-Mattei J, Mitchell JD. Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification. JACC CardioOncol. [internet] 2021 21;3(3):343-359. Available from: https://doi.org/10.1016/j.jaccao.2021.06.007 PMID: 34604796; PMCID: PMC8463722.
info:eu-repo/semantics/openAccess
Padegimas A, Clasen S, Ky B. Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity. Trends Cardiovasc Med. [internet] 2020 Jan;30(1):22-28. Available from: https://doi.org/10.1016/j.tcm.2019.01.006 PMID: 30745071; PMCID: PMC7287268.
Koulaouzidis G, Yung AE, Yung DE, Skonieczna-Żydecka K, Marlicz W, Koulaouzidis A, Charisopoulou D. Conventional cardiac risk factors associated with trastuzumab-induced cardiotoxicity in breast cancer: Systematic review and meta-analysis. CurrProblCancer. [internet] 2021 Oct;45(5):100723. Available from: https://doi.org/10.1016/j.currproblcancer.2021.100723 PMID: 33726923.
Ruiz-Mori E, Ayala-Bustamante L, Burgos-Bustamante J, et al. Cardiotoxicidad por quimioterapia en el Instituto Nacional de Enfermedades Neoplásicas 2012-2016. HorizMéd Lima. [internet] 2017; 17(3):24-8. Available from: http://dx.doi.org/10.24265/horizmed.2017.v17n3.05
Text
https://revista.acho.info/index.php/acho/article/download/703/637
info:eu-repo/semantics/article
http://purl.org/coar/resource_type/c_6501
http://purl.org/coar/resource_type/c_2df8fbb1
http://purl.org/redcol/resource_type/ART
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/version/c_970fb48d4fbd8a85
Jerusalem G, Lancellotti P, Kim SB. HER2+ breast cancer treatment and cardiotoxicity: monitoring and management. Breast Cancer Res Treat. [internet] 2019; 177(2):237-250. Available from: https://doi.org/10.1007/s10549-019-05303-y PMID: 31165940; PMCID: PMC6661020.
Revista colombiana de hematología y oncología - 2024
Keshavarzian E, Sadighpour T, Mortazavizadeh SM, Soltani M, Motevalipoor AF, et al. Prophylactic Agents for Preventing Cardiotoxicity Induced Following Anticancer Agents: A Systematic Review and Meta-Analysis of Clinical Trials. RevRecent Clin Trials. [internet] 2023; 18(2):112-122. Available from: https://doi.org/10.2174/1574887118666230118102252
2024-12-05
cardiotoxicity
global longitudinal strain
stroke volume
anthracyclines
trastuzumab
cardiotoxicidad
tensión longitudinal global
volumen de ictus
antraciclinas
trastuzumab
2024-12-05 00:00:00
2024-12-05 00:00:00
application/pdf
Kong CY, Guo Z, Song P, Zhang X, Yuan YP, Teng T, Yan L, Tang QZ. Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death. Int J Biol Sci. [internet] 2022;18(2):760-770. Available from: https://doi.org/10.7150/ijbs.65258
2256-2877
2256-2915
https://revista.acho.info/index.php/acho/article/view/703
10.51643/22562915.703
https://doi.org/10.51643/22562915.703
https://creativecommons.org/licenses/by-nc-nd/4.0
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
22
34
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. [internet] 2021; 71(3):209-249. Available from: https://doi.org/10.3322/caac.21660
Waks AG, Winer EP. Breast Cancer Treatment: A Review. JAMA. [internet] 2019 22; 321(3):288-300. Available from: https://doi.org/10.1001/jama
Publication
institution ASOCIACION COLOMBIANA DE HEMATOLOGIA Y ONCOLOGIA
thumbnail https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADEHEMATOLOGIAYONCOLOGIA/logo.png
country_str Colombia
collection Revista Colombiana de Hematología y Oncología
title Prediction of cardiotoxicity in breast cancer patients exposed to anthracyclines during trastuzumab treatment.
spellingShingle Prediction of cardiotoxicity in breast cancer patients exposed to anthracyclines during trastuzumab treatment.
Medina Pabón , Miguel Ángel
Gómez Wolff, Luis Rodolfo
Jaramillo Gómez , Nicolás Ignacio
Tatis Mendez, Jose Fidel
Llamas Jiménez , Alexis del Carmen
Lopera Arrázola , Nicolás
cardiotoxicity
global longitudinal strain
stroke volume
anthracyclines
trastuzumab
cardiotoxicidad
tensión longitudinal global
volumen de ictus
antraciclinas
trastuzumab
title_short Prediction of cardiotoxicity in breast cancer patients exposed to anthracyclines during trastuzumab treatment.
title_full Prediction of cardiotoxicity in breast cancer patients exposed to anthracyclines during trastuzumab treatment.
title_fullStr Prediction of cardiotoxicity in breast cancer patients exposed to anthracyclines during trastuzumab treatment.
title_full_unstemmed Prediction of cardiotoxicity in breast cancer patients exposed to anthracyclines during trastuzumab treatment.
title_sort prediction of cardiotoxicity in breast cancer patients exposed to anthracyclines during trastuzumab treatment.
author Medina Pabón , Miguel Ángel
Gómez Wolff, Luis Rodolfo
Jaramillo Gómez , Nicolás Ignacio
Tatis Mendez, Jose Fidel
Llamas Jiménez , Alexis del Carmen
Lopera Arrázola , Nicolás
author_facet Medina Pabón , Miguel Ángel
Gómez Wolff, Luis Rodolfo
Jaramillo Gómez , Nicolás Ignacio
Tatis Mendez, Jose Fidel
Llamas Jiménez , Alexis del Carmen
Lopera Arrázola , Nicolás
topic cardiotoxicity
global longitudinal strain
stroke volume
anthracyclines
trastuzumab
cardiotoxicidad
tensión longitudinal global
volumen de ictus
antraciclinas
trastuzumab
topic_facet cardiotoxicity
global longitudinal strain
stroke volume
anthracyclines
trastuzumab
cardiotoxicidad
tensión longitudinal global
volumen de ictus
antraciclinas
trastuzumab
citationvolume 11
citationissue 2
citationedition Núm. 2 , Año 2024 : Julio - Diciembre
publisher Bogotá: Asociación Colombiana de Hematología y Oncología, 2012-
ispartofjournal Revista Colombiana de Hematología y Oncología
source https://revista.acho.info/index.php/acho/article/view/703
language
format Article
rights http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
Revista colombiana de hematología y oncología - 2024
https://creativecommons.org/licenses/by-nc-nd/4.0
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
type_driver info:eu-repo/semantics/article
type_coar http://purl.org/coar/resource_type/c_6501
type_version info:eu-repo/semantics/publishedVersion
type_coarversion http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content Text
publishDate 2024-12-05
date_accessioned 2024-12-05 00:00:00
date_available 2024-12-05 00:00:00
url https://revista.acho.info/index.php/acho/article/view/703
url_doi https://doi.org/10.51643/22562915.703
issn 2256-2877
eissn 2256-2915
doi 10.51643/22562915.703
citationstartpage 22
citationendpage 34
url2_str_mv https://revista.acho.info/index.php/acho/article/download/703/637
_version_ 1830444207153610752